DUSA Share Price

Open 8.00 Change Price %
High 8.01 1 Day 0.02 0.25
Low 7.98 1 Week 0.00 0.00
Close 8.00 1 Month 0.00 0.00
Volume 1356303 1 Year 0.00 0.00
52 Week High 53.90
52 Week Low 49.43
DUSA Important Levels
Resistance 2 8.03
Resistance 1 8.02
Pivot 8.00
Support 1 7.98
Support 2 7.97
NASDAQ USA Most Active Stocks
SIRI 4.30 -5.49%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
QQQ 115.70 0.20%
WRES 0.09 0.00%
More..
NASDAQ USA Top Gainers Stocks
QKLS 0.21 110.00%
LOCM 0.09 50.00%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
PERF 1.90 22.58%
ASNA 7.01 20.24%
SBSA 4.60 17.95%
CEMP 7.55 15.27%
XXIA 15.55 14.76%
More..
NASDAQ USA Top Losers Stocks
PTIX 0.00 -100.00%
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
AMCF 0.03 -50.00%
VALV 0.03 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
RITT 0.06 -45.45%
More..

DUSA Pharmaceuticals, Inc. (NASDAQ: DUSA)

DUSA Technical Analysis 5
As on 20th Dec 2012 DUSA Share Price closed @ 8.00 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 5.93 & Strong Buy for SHORT-TERM with Stoploss of 7.34 we also expect STOCK to react on Following IMPORTANT LEVELS.
DUSA Target for December
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
DUSA Other Details
Segment EQ
Market Capital 155506272.00
Sector Consumer Durables Major Pharmaceuticals
Industry
Offical website
DUSA Address
DUSA
N/A
DUSA Latest News
Interactive Technical Analysis Chart DUSA Pharmaceuticals, Inc. ( DUSA NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on DUSA Pharmaceuticals, Inc.
DUSA Business Profile
DUSA Pharmaceuticals, Inc. (DUSA) is a vertically integrated dermatology company. The Company is developing and marketing Levulan photodynamic therapy (Levulan PDT). The Company�s marketed products include Levulan Kerastick 20% topical solution with PDT and the BLU-U brand light source. Levulan Kerastick and BLU-U are used for the treatment of non-hyperkeratotic actinic keratoses (AKs), of the face or scalp. During the year ended December 31, 2011, it initiated an exploratory DUSA-sponsored clinical trial designed to study the broad area application and/or short drug incubation (BASDI), method of using the Levulan Kerastick, which is being carried out at 10 clinical trial sites. DUSA manufactures its Levulan Kerastick in its Wilmington, Massachusetts facility. Its wholly owned subsidiaries include DUSA Pharmaceuticals New York, Inc. and Sirius Laboratories, Inc. As of December 31, 2011, DUSA ceased marketing and selling its remaining Non-PDT products, which were ClindaReach and Meted.